Superficial siderosis is a progressively deteriorating neurological condition that must be recognized early in order to be effectively treated. The accumulated data on patients with the condition ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

and superficial siderosis), ARIA-E (oedema/effusion), headache, and fall. The findings reported that deaths occurred in 0.7% and 0.8% of participants in the lecanemab and placebo groups ...

The number of APOE ε4 alleles and the presence of cortical superficial siderosis were linked to a higher risk of developing ARIA. The TRAILBLAZER-ALZ 6 trial tested alternative dosing regimens. A ...

Among other adverse events, the risk of superficial siderosis of the central nervous system was notably higher and statistically significant. Conclusion: Lecanemab/Donanemab can improve memory, ...

In 2024, the European Medicines Agency (EMA) approved lecanemab for the treatment of early Alzheimer's disease in patients without contraindications or risk factors for side-effects. This approval ...

ORLANDO, Fla. — Beyond appropriate use criteria for Mohs surgery outlined by a multidisciplinary ad hoc task force in 2012, choice of treatment for superficial skin cancers like basal cell ...

With San Jose again heavily investing in addressing homelessness, city leaders believe they are making tangible progress and finally moving the needle on public perception. But despite the city ...

Dr. Paul Atkin exclusively spoke with PEOPLE about his 'thoughtful' conversation with the royal during a reception in Rome Chris Jackson/Getty King Charles and Queen Camilla meet many people from ...

The financial decline of some of the city’s most popular clubs has put a spotlight on the realities of nightlife. Nightclubs in Brooklyn have been going out of business in recent months despite ...